Previous 10 | Next 10 |
Galmed Pharmaceuticals to Report Fourth Quarter and Year End 2020 Financial Results and Provide Business Update on Thursday March 18 PR Newswire TEL AVIV, Israel , March 11, 2021 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company...
Galmed Pharmaceuticals ([[GLMD]] -8.4%) announces the pricing of the underwritten public offering of 2.19M shares for gross proceeds of about $10M.The offering is expected to close on or about February 18, 2021.Galmed intends to use the net proceeds of the offering for continued development o...
Galmed Pharmaceuticals Announces Pricing of $10 Million Public Offering of Ordinary Shares PR Newswire TEL AVIV, Israel , Feb. 16, 2021 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical comp...
bluebird bio (BLUE) -30% after suspending sickle cell disease trial.Hepion Pharmaceuticals (HEPA) -28% after pricing stock offering.Cortexyme (CRTX) -26% after regulatory update on Atuzaginstat in Alzheimer’s Disease.Neptune Wellness Solutions (NEPT) -21%&...
Galmed Pharmaceuticals (GLMD) commences a public offering of its Ordinary Shares.Underwriter's over-allotment is an additional 15% of shares.Price, size and terms are not yet determined.Shares down 4% premarket. For further details see: Galmed Pharma slips 4% on launch of shar...
Galmed Pharmaceuticals Announces Proposed Offering of Ordinary Shares PR Newswire TEL AVIV, Israel , Feb. 16, 2021 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabo...
Galmed Pharmaceuticals Announces Upcoming Publication in JHEP Reports of New Data Supporting Aramchol's Novel Anti-Fibrotic Mechanism of Action - Galmed KOL Symposium and Pipeline Update taking place later today at 11 a.m. Eastern time PR Newswire TEL AVIV, Israel ...
welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report.Monda...
Galmed Hosting KOL Symposium and Pipeline Update Aramchol Phase 3 Trial for Non-Alcoholic Steatohepatitis and Liver Fibrosis Amilo-5MER for Chronic Inflammatory Disorders Symposium Being Held January 26th at 11am Eastern Time PR Newswire TEL AVIV, Israel ...
Galmed to add Open Label Part to ARMOR Study; First Read-out Expected in Q4 2021 TEL AVIV, Israel , Dec. 17, 2020 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and i...
News, Short Squeeze, Breakout and More Instantly...
Galmed Pharmaceuticals Ltd. Company Name:
GLMD Stock Symbol:
NASDAQ Market:
Galmed Pharmaceuticals Ltd. Website: